Current advances on the therapeutic potential of scutellarin: an updated review.
- 2024-03-04
- Natural products and bioprospecting 14(1)
- Yifei Xie
- Guotong Sun
- Yue Tao
- Wen Zhang
- Shiying Yang
- Li Zhang
- Yang Lu
- Guanhua Du
- PubMed: 38436812
- DOI: 10.1007/s13659-024-00441-3
Study Design
- Type
- Review
Scutellarin is widely distributed in Scutellaria baicalensis, family Labiatae, and Calendula officinalis, family Asteraceae, and belongs to flavonoids. Scutellarin has a wide range of pharmacological activities, it is widely used in the treatment of cerebral infarction, angina pectoris, cerebral thrombosis, coronary heart disease, and other diseases. It is a natural product with great research and development prospects. In recent years, with in-depth research, researchers have found that wild scutellarin also has good therapeutic effects in anti-tumor, anti-inflammatory, anti-oxidation, anti-virus, treatment of metabolic diseases, and protection of kidney. The cancer treatment involves glioma, breast cancer, lung cancer, renal cancer, colon cancer, and so on. In this paper, the sources, pharmacological effects, in vivo and in vitro models of scutellarin were summarized in recent years, and the current research status and future direction of scutellarin were analyzed.